Cargando…
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
A common key regulator of oncogenic signaling pathways in multiple tumor types is the unique isomerase Pin1. However, available Pin1 inhibitors lack the required specificity and potency. Using mechanism-based screening, here we find that all-trans retinoic acid (ATRA)--a therapy for acute promyelocy...
Autores principales: | Wei, Shuo, Kozono, Shingo, Kats, Lev, Nechama, Morris, Li, Wenzong, Guarnerio, Jlenia, Luo, Manli, You, Mi-Hyeon, Yao, Yandan, Kondo, Asami, Hu, Hai, Bozkurt, Gunes, Moerke, Nathan J., Cao, Shugeng, Reschke, Markus, Chen, Chun-Hau, Rego, Eduardo M., LoCoco, Francesco, Cantley, Lewis, Lee, Tae Ho, Wu, Hao, Zhang, Yan, Pandolfi, Pier Paolo, Zhou, Xiao Zhen, Lu, Kun Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425616/ https://www.ncbi.nlm.nih.gov/pubmed/25849135 http://dx.doi.org/10.1038/nm.3839 |
Ejemplares similares
-
HIF factors cooperate with PML-RARα to promote acute promyelocytic leukemia progression and relapse
por: Coltella, Nadia, et al.
Publicado: (2014) -
Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells
por: Kozono, Shingo, et al.
Publicado: (2018) -
Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress
por: Masciarelli, S, et al.
Publicado: (2018) -
Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005) -
Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
por: Lehmann-Che, Jacqueline, et al.
Publicado: (2018)